Anzemet Dosage

The recommended Anzemet dosage for the prevention of nausea and vomiting caused by chemotherapy is 100 mg, taken an hour before the start of chemotherapy. To help prevent nausea and vomiting due to surgery, you can also take 100 mg of Anzemet within two hours before surgery. Anzemet dosing for children ages 2 to 16 is generally based on the child's body weight.

 

Anzemet Dosage: An Introduction

The dose of Anzemet® (dolasetron mesylate) that your healthcare provider recommends will vary depending on a number of factors, including:
 
  • Your age and weight
  • Whether you are having surgery or chemotherapy
  • Other medications you may be taking
  • Other medical conditions you may have.
     
As is always the case, do not adjust your Anzemet dose unless your healthcare provider specifically instructs you to do so.
 

Anzemet Dosing for Surgery

For adults, the recommended Anzemet dose for the prevention of nausea and vomiting due to surgery is 100 mg taken by mouth within two hours before surgery. For children ages 2 to 16, the recommended dose is based on weight -- Anzemet 1.2 mg per kg of body weight (about 0.54 mg per pound) taken by mouth within two hours before surgery.
 
An injectable form of Anzemet is also available to be given during surgery for preventing nausea and vomiting (or to treat nausea and vomiting once it starts).
 

Anzemet Dosing for Chemotherapy

For adults, the recommended Anzemet dose for the prevention of nausea and vomiting due to chemotherapy is 100 mg taken by mouth within one hour before chemotherapy. For children ages 2 to 16, the recommended dose is based on weight -- Anzemet 1.8 mg per kg of body weight (about 0.8 mg per pound) taken by mouth within one hour before chemotherapy.
 
An injectable form of Anzemet is also available to be given by IV about 30 minutes before chemotherapy.
 
(Anzemet Dosage Continued: Page 2)
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;